PINL:GRPOF - Post by User
Post by
shrinkon Feb 16, 2018 9:01am
97 Views
Post# 27570754
Globe Report
Globe Report Seems like there is a market for cannabis that has some science behind it.
Globe says Canopy, rivals hear call for med pot limits
2018-02-16 08:25 ET - In the News
See In the News (C-WEED) Canopy Growth Corp
The Globe and Mail reports in its Friday edition that new medical pot guidelines for family doctors stress that they should authorize it for only a small fraction of patients because many of its reported benefits have not been proved by clinical trials. The Globe's Mike Hager writes that the guidelines, published Thursday in the Canadian Family Physician journal, warn that the number of randomized studies backing up the use of cannabis to fight various ailments is "extremely limited or entirely absent." The scientific evidence dictates that doctors should recommend the drug only when treating a handful of very specific medical conditions such as: chronic nerve pain, palliative cancer pain, muscle stiffness associated with multiple sclerosis or spinal cord injuries and the nausea and vomiting brought on by chemotherapy. Even then, patients should first consider synthetic cannabis pills and sprays now available at pharmacies before purchasing dried cannabis or oil products through Health Canada's mail-order system. The committee that drafted the guidelines found little to no acceptable clinical evidence that cannabis helps other conditions commonly cited by patients such as arthritis and anxiety or depression.